E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/5/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: MannKind discloses details on $175 million private placement of stock

By Sheri Kasprzak

New York, Aug. 5 - MannKind Corp. has released the details of its previously announced $175,000,131 private placement.

The company sold 17,131,682 shares at $10.215 each to Adage Capital Partners LP, Biomed Partners, LLC, Amaranth Global Equities Master Fund Ltd., Amaranth LLC, Atlas Master Fund, Ltd., Brookside Capital Partners Fund, LP, D3 LifeScience Ltd., Deerfield International Ltd., Deerfield Partners LP, Fidelity Contrafund: Fidelity Advisory New Insights Fund, Vanable Insurance Partners Fund II, Contrafund Portfolio, Aries Domestic Fund LP, Aries Domestic Fund II, LP, Aries Master Fund II, Oracle U.S. Partners LLC, Narragansett, LP, Narragansett Offshore, Ltd., The Edtrom Family Trust, The Kensa Family Trust, T. Rowe Price Associates, Tange Capital Partners, Kings Road Investments Ltd. and MannKind chief executive officer Alfred E. Mann's family trust.

The investors also received warrants for 3,426,340 shares, exercisable at $12.228 each through Aug. 5, 2010.

Wachovia Capital Markets, LLC and Leerink Swann & Co. were the placement agents for the offering.

Based in Valencia, Calif., MannKind is a biotechnology company focused on therapeutic treatments for cancer and diabetes.

Issuer:MannKind Corp.
Issue:Stock
Amount:$175,000,131
Shares:17,131,682
Price:$10.215
Warrants:For 3,426,340 shares
Warrant expiration:Aug. 5, 2010
Warrant strike price:$12.228
Investors:Adage Capital Partners LP, Biomed Partners, LLC, Amaranth Global Equities Master Fund Ltd., Amaranth LLC, Atlas Master Fund, Ltd., Brookside Capital Partners Fund, LP, D3 LifeScience Ltd., Deerfield International Ltd., Deerfield Partners LP, Fidelity Contrafund: Fidelity Advisory New Insights Fund, Vanable Insurance Partners Fund II, Contrafund Portfolio, Aries Domestic Fund LP, Aries Domestic Fund II, LP, Aries Master Fund II, Oracle U.S. Partners LLC, Narragansett, LP, Narragansett Offshore, Ltd., The Edtrom Family Trust, The Kensa Family Trust, T. Rowe Price Associates, Tange Capital Partners, Kings Road Investments Ltd., Alfred E. Mann family trust
Placement agents:Wachovia Capital Markets, LLC, Leerink Swann & Co.
Settlement date:Aug. 5
Stock price:$11.00 at close Aug. 5

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.